SlideShare a Scribd company logo
1 of 32
CONCEPT OF LOADING AND
MAINTENANCE DOSE
6/5/2022 1
CONTENT
 INTRODUCTION
 DEFINITION
 CONCEPT
 FACTORS
 REFERENCE
6/5/2022 2
INTRODUCTION
 Most drugs for chronic condition are
prescribed in a dosage regimen is
based on the administration of a fixed
constant dose(D) at fixed regular
dosing intervals(T) for long period of
time.
 The D & T recommended by the
manufacturer is based on the effective
therapeutic concentration of drug in
the plasma needed to treat the chronic
condition.
6/5/2022 3
 The T is based on elimination rate
constant of the drug.
 The steady-state concentration of drug
in plasma during multiple dosing is
given by following equation:
6/5/2022 4
 The concentration of drug in plasma at
steady-state depends on the following
3 factors:
a) C0, concentration of drug in plasma.
b) Ke, elimination rate constant.
c) T, the dosing interval.
6/5/2022 5
DEFINITION & CONCEPT
 Loading dose: A dose of medication,
often larger than subsequent doses,
administered for the purpose of
establishing a therapeutic level of the
medication.
 Primary purpose of using loading dose in
therapeutic treatment is to attain steady-
state concentration of the drug as quickly
as possible, usually right from the start of
the dosage regimen for the treatment.
6/5/2022 6
 This approach may also reduce the
time of onset of drug action, i.e; the
time its takes to achieve the minimum
effective concentration.
 The purpose of administering the
loading dose is to reduce the time
needed for the drug to accumulate to
the steady-state level in the plasma.
 The size of loading dose will depend
on the T of the maintenance dose.
6/5/2022 7
INTRAVENOUS
ADMINISTRATION
 A drug when administered
intravenously as a single rapid bolus
dose, confers the characteristics of
one-compartment model on the body.
 The main purpose of loading dose(D*)
is to provide a steady-state
concentration in plasma during
multiple dosing.
6/5/2022 8
Loading dose based on Cmax
ss
 The max concentration of drug in the
plasma at steady-state, Cmax ss is given
by equation
C0 is plasma concentration
immediately after administration of a
single dose.
e-p is persistence factor where P=(Ke)
(T) 6/5/2022 9
 If the drug follows linear
pharmacokinetics then C0 obtained
after the administration of single i.v
rapid bolus dose is directly
proportional to size of dose
D(maintenance dose).
 The max concentration at steady-state
is
6/5/2022 10
 Concentration of drug in plasma
immediately after administration of the
first dose is given by
 Vd= apparent volume of distribution
 therefore
6/5/2022 11
 The max conc after the first dose is
 Since Cmax 1 = Cmaxss, the conc *C0 of
drug in plasma immediately after (D*) is
given by
*C0 = Cmaxss
 Substuting *C0 and Cmaxss gives
6/5/2022 12
 The size of loading dose depends on
the following factors-
a) Maintenance dose ,D
b) Elimination rate constant , Ke
c) Dosing interval ,T.
6/5/2022 13
Loading dose based on Cmin ss
 The minimum concentration of drug in
plasma at steady-state is given by
equation
 If drug follows linear p’kinetics then C0
is directly proportional to size of D
 The min concentration of drug in
plasma at steady-state is
6/5/2022 14
 When a single bolus dose of the drug
is administered intravenously
 Therefore
6/5/2022 15
 The min conc of drug in plasma after
administration of first dose
 For D* Cmin 1 = (*C0 ) (e-p ),which
should be equal to Cmin ss
 Combining eq
6/5/2022 16
 Common terms canceled
6/5/2022 17
Factors affecting size of dose
 If all doses and all T are kept
constant, then the size of D depends
on size of D*, T & Ke
Effect of dosing interval:
 If the size of D is kept constant &
biological halflife of the drug dose not
change during the course of therapy,
the size of D* depends entirely upon
the T of a given drug.
6/5/2022 18
EXTRAVASCULAR
ADMINISTRATION
 For the determination of D* during e.v,
administration, the simplest case is a
drug which, when administered,
confers upon the body the
characteristics of one-compartment
model, & does not exhibit lag-time.
 The size of D* needed to attain
steady-sate conc of drug in plasma
depends on:
6/5/2022 19
a. Maximum concentration of drug in
plasma at steady state. OR
b. Minimum concentration of drug in
plasma at steady state.
LOADING DOSE BASED ON Cmaxss
 The maximum concn of drug in
plasma at steady-state is given by
6/5/2022 20
 Where B is the back extrapolated y-
intercept of the elimination phase after
administration of a single dose.
 R=(Ke) (tmax)
6/5/2022 21
Loading dose based on Cmin ss
 The minimum conc of drug in plasma
following e.v adminstration of n dose
 If the drug follows linear
pharmacokinetics then B
 F=fraction of dose absorbed
 G= (Ka)( T)
6/5/2022 22
 By setting n=1 in above eq in Cmin1
 Canceling common terms
 When n becomes large, the two
exponential terms e-np e-nG approach 0
6/5/2022 23
 Since the y-intercept,Cmin1 is directly
proportional to D
 If D is administered at the first dose
6/5/2022 24
 When Cmin1=Cminss
 Substituting the values
 Bringing RHS of eq to common
denominator
 Upon simplification
6/5/2022 25
 Dividing both side by (e-p – e-G)
 Cancelling common term
6/5/2022 26
Maintenance Dose
 After the loading dose is given the
another dose is given to maintain the
steady- state drug conc. / plateau.
Such dose is known as maintenance
dose.
 i.e. maintain the response of drug by
replacing drug lost during dosing
interval
6/5/2022 27
 Maintenance dose = loading dose . ( 1- e k‫ז‬)
 Loading dose =
 The ratio of loading dose to maintenance
dose (X0l/X0) is called as dose ratio
 When ‫ז‬ = t1/2 the dose ratio =2.0
 When ‫ז‬ > t1/2 the dose ratio < 2.0
 when ‫ז‬ < t1/2 the dose ratio >2.0
6/5/2022 28
6/5/2022 29
Maintenance of drug within the
therapeutic range
The ease or difficulty in maintaining drug
concentration within the therapeutic
window depends on-
 The Therapeutic index of drug
 The Half- life of drug
 Convenience of dosing
6/5/2022 30
REFERENCE
 Madan PL;Biopharmaceutics and
pharmacokinetics. Jaypee.2010(1);365-80.
 Brahmankar DM, Sunil Jaiswal B;
Biopharmaceutics and Pharmacokinetics-
A Treatise. Vallabh publication. 2014(3);
374-76.
 C V S Subrahmanyam. Textbook of
Biopharmaceutics & pharmacokinetics.1st
edition 2010;456-61.
6/5/2022 31
6/5/2022 32

More Related Content

What's hot

Two compartment model
Two compartment modelTwo compartment model
Two compartment modelRooma Khalid
 
Concept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretionConcept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretionchiranjibi68
 
Estimation of pharmacokinetic parameters
Estimation of pharmacokinetic parametersEstimation of pharmacokinetic parameters
Estimation of pharmacokinetic parametersKarun Kumar
 
Methods for Measurement of bioavailability
Methods for Measurement of bioavailability Methods for Measurement of bioavailability
Methods for Measurement of bioavailability pharmacampus
 
One compartment model IV Infusion
One compartment model IV InfusionOne compartment model IV Infusion
One compartment model IV InfusionLakshmiChandran20
 
Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kineticsSujit Patel
 
Biopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug AbsorptionBiopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug AbsorptionSURYAKANTVERMA2
 
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolus
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolusPharmacokinetics / Biopharmaceutics - One compartment model IV bolus
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolusAreej Abu Hanieh
 
Urinaryexcreation studies
Urinaryexcreation studiesUrinaryexcreation studies
Urinaryexcreation studiesSonam Gandhi
 
Pharmacokinetics / Biopharmaceutics - Multi dosage regimens
Pharmacokinetics / Biopharmaceutics - Multi dosage regimensPharmacokinetics / Biopharmaceutics - Multi dosage regimens
Pharmacokinetics / Biopharmaceutics - Multi dosage regimensAreej Abu Hanieh
 
A seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administrationA seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administrationMalla Reddy College of Pharmacy
 
Non linear Pharmacokinetics
Non linear PharmacokineticsNon linear Pharmacokinetics
Non linear PharmacokineticsAreej Abu Hanieh
 
Protein binding of drug.ppt
Protein binding of drug.pptProtein binding of drug.ppt
Protein binding of drug.pptramchoure90
 
Bio pharmaceutical classification System [BCS]
Bio pharmaceutical classification System [BCS]Bio pharmaceutical classification System [BCS]
Bio pharmaceutical classification System [BCS]Sagar Savale
 
Pharmacokinetics / Biopharmaceutics - Multi compartment IV bolus
Pharmacokinetics / Biopharmaceutics - Multi compartment IV bolusPharmacokinetics / Biopharmaceutics - Multi compartment IV bolus
Pharmacokinetics / Biopharmaceutics - Multi compartment IV bolusAreej Abu Hanieh
 
Seminar on pharmacokinetic parameters of two compartment open model
Seminar on pharmacokinetic parameters of two compartment open modelSeminar on pharmacokinetic parameters of two compartment open model
Seminar on pharmacokinetic parameters of two compartment open modelDivya Singh
 

What's hot (20)

Two compartment model
Two compartment modelTwo compartment model
Two compartment model
 
Pharmacokinetic models
Pharmacokinetic modelsPharmacokinetic models
Pharmacokinetic models
 
Concept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretionConcept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretion
 
Estimation of pharmacokinetic parameters
Estimation of pharmacokinetic parametersEstimation of pharmacokinetic parameters
Estimation of pharmacokinetic parameters
 
Methods for Measurement of bioavailability
Methods for Measurement of bioavailability Methods for Measurement of bioavailability
Methods for Measurement of bioavailability
 
One compartment model IV Infusion
One compartment model IV InfusionOne compartment model IV Infusion
One compartment model IV Infusion
 
Pharmacokinetics of multiple dosing
Pharmacokinetics of multiple dosingPharmacokinetics of multiple dosing
Pharmacokinetics of multiple dosing
 
Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kinetics
 
Biopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug AbsorptionBiopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug Absorption
 
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolus
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolusPharmacokinetics / Biopharmaceutics - One compartment model IV bolus
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolus
 
Urinaryexcreation studies
Urinaryexcreation studiesUrinaryexcreation studies
Urinaryexcreation studies
 
Pharmacokinetics / Biopharmaceutics - Multi dosage regimens
Pharmacokinetics / Biopharmaceutics - Multi dosage regimensPharmacokinetics / Biopharmaceutics - Multi dosage regimens
Pharmacokinetics / Biopharmaceutics - Multi dosage regimens
 
Multiple Dosage regimen
Multiple Dosage regimenMultiple Dosage regimen
Multiple Dosage regimen
 
A seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administrationA seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administration
 
Loading dose plus iv infusion
Loading dose plus iv infusionLoading dose plus iv infusion
Loading dose plus iv infusion
 
Non linear Pharmacokinetics
Non linear PharmacokineticsNon linear Pharmacokinetics
Non linear Pharmacokinetics
 
Protein binding of drug.ppt
Protein binding of drug.pptProtein binding of drug.ppt
Protein binding of drug.ppt
 
Bio pharmaceutical classification System [BCS]
Bio pharmaceutical classification System [BCS]Bio pharmaceutical classification System [BCS]
Bio pharmaceutical classification System [BCS]
 
Pharmacokinetics / Biopharmaceutics - Multi compartment IV bolus
Pharmacokinetics / Biopharmaceutics - Multi compartment IV bolusPharmacokinetics / Biopharmaceutics - Multi compartment IV bolus
Pharmacokinetics / Biopharmaceutics - Multi compartment IV bolus
 
Seminar on pharmacokinetic parameters of two compartment open model
Seminar on pharmacokinetic parameters of two compartment open modelSeminar on pharmacokinetic parameters of two compartment open model
Seminar on pharmacokinetic parameters of two compartment open model
 

Similar to CONCEPT OF LOADING AND MAINTAINANCE DOSE.pptx

Pharmacokinetics II: Basic Concepts and Drug Clearance
Pharmacokinetics II: Basic Concepts and Drug ClearancePharmacokinetics II: Basic Concepts and Drug Clearance
Pharmacokinetics II: Basic Concepts and Drug ClearanceImhotep Virtual Medical School
 
Multiple Dosage Oral Administration/ Dosage Regimen
Multiple Dosage Oral Administration/ Dosage Regimen Multiple Dosage Oral Administration/ Dosage Regimen
Multiple Dosage Oral Administration/ Dosage Regimen Nausheen Fatima
 
pharmacokinetics .Pharm.D(one compartment).pptx
pharmacokinetics .Pharm.D(one compartment).pptxpharmacokinetics .Pharm.D(one compartment).pptx
pharmacokinetics .Pharm.D(one compartment).pptxrameshjanga11
 
Biopharmaceutics: Multiple dosage regimens
Biopharmaceutics: Multiple dosage regimensBiopharmaceutics: Multiple dosage regimens
Biopharmaceutics: Multiple dosage regimensSonia Barua
 
Application of pharmacokinetics
Application of pharmacokineticsApplication of pharmacokinetics
Application of pharmacokineticsChristy George
 
sustained release oral dosage forms
sustained release oral dosage formssustained release oral dosage forms
sustained release oral dosage formskajal pradhan
 
Determination of dose and dosing interval
Determination of dose and dosing intervalDetermination of dose and dosing interval
Determination of dose and dosing intervalDr. Ramesh Bhandari
 
Therapeutic Drugs Monitoring
Therapeutic Drugs Monitoring Therapeutic Drugs Monitoring
Therapeutic Drugs Monitoring wadalshigil84
 
PHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELS
PHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELSPHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELS
PHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELSDollySadrani
 
Determination of dose and dosing interval
Determination of dose and dosing intervalDetermination of dose and dosing interval
Determination of dose and dosing intervalDr. Ramesh Bhandari
 
Introduction to dosage regimen and Individualization of dosage regimen
Introduction to dosage regimen and Individualization of dosage regimenIntroduction to dosage regimen and Individualization of dosage regimen
Introduction to dosage regimen and Individualization of dosage regimenKLE College of pharmacy
 
SUSTAINDRUG DELIVERY SYSTEMS power point
SUSTAINDRUG DELIVERY SYSTEMS power pointSUSTAINDRUG DELIVERY SYSTEMS power point
SUSTAINDRUG DELIVERY SYSTEMS power pointSonam Gandhi
 
APPLICATIONS OF PHARMACOKINETICS Piyush lodhi b. pharma 6th sem
APPLICATIONS OF  PHARMACOKINETICS Piyush lodhi b. pharma 6th sem APPLICATIONS OF  PHARMACOKINETICS Piyush lodhi b. pharma 6th sem
APPLICATIONS OF PHARMACOKINETICS Piyush lodhi b. pharma 6th sem Drx Piyush Lodhi
 

Similar to CONCEPT OF LOADING AND MAINTAINANCE DOSE.pptx (20)

Kinetics of multiple dosing
Kinetics of multiple dosingKinetics of multiple dosing
Kinetics of multiple dosing
 
Pharmacokinetics II: Basic Concepts and Drug Clearance
Pharmacokinetics II: Basic Concepts and Drug ClearancePharmacokinetics II: Basic Concepts and Drug Clearance
Pharmacokinetics II: Basic Concepts and Drug Clearance
 
Multiple Dosage Oral Administration/ Dosage Regimen
Multiple Dosage Oral Administration/ Dosage Regimen Multiple Dosage Oral Administration/ Dosage Regimen
Multiple Dosage Oral Administration/ Dosage Regimen
 
multiple-dosage-regimen.pdf
multiple-dosage-regimen.pdfmultiple-dosage-regimen.pdf
multiple-dosage-regimen.pdf
 
pharmacokinetics .Pharm.D(one compartment).pptx
pharmacokinetics .Pharm.D(one compartment).pptxpharmacokinetics .Pharm.D(one compartment).pptx
pharmacokinetics .Pharm.D(one compartment).pptx
 
Biopharmaceutics: Multiple dosage regimens
Biopharmaceutics: Multiple dosage regimensBiopharmaceutics: Multiple dosage regimens
Biopharmaceutics: Multiple dosage regimens
 
Application of pharmacokinetics
Application of pharmacokineticsApplication of pharmacokinetics
Application of pharmacokinetics
 
Multiple Dosage Regimens
Multiple Dosage RegimensMultiple Dosage Regimens
Multiple Dosage Regimens
 
sustained release oral dosage forms
sustained release oral dosage formssustained release oral dosage forms
sustained release oral dosage forms
 
Gentamicin tdm
Gentamicin tdmGentamicin tdm
Gentamicin tdm
 
Determination of dose and dosing interval
Determination of dose and dosing intervalDetermination of dose and dosing interval
Determination of dose and dosing interval
 
Therapeutic Drugs Monitoring
Therapeutic Drugs Monitoring Therapeutic Drugs Monitoring
Therapeutic Drugs Monitoring
 
PHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELS
PHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELSPHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELS
PHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELS
 
Elementary pharmacokinetics jap
Elementary pharmacokinetics japElementary pharmacokinetics jap
Elementary pharmacokinetics jap
 
Determination of dose and dosing interval
Determination of dose and dosing intervalDetermination of dose and dosing interval
Determination of dose and dosing interval
 
Kinetika En 2002
Kinetika En 2002Kinetika En 2002
Kinetika En 2002
 
Kinetika En 2002
Kinetika En 2002Kinetika En 2002
Kinetika En 2002
 
Introduction to dosage regimen and Individualization of dosage regimen
Introduction to dosage regimen and Individualization of dosage regimenIntroduction to dosage regimen and Individualization of dosage regimen
Introduction to dosage regimen and Individualization of dosage regimen
 
SUSTAINDRUG DELIVERY SYSTEMS power point
SUSTAINDRUG DELIVERY SYSTEMS power pointSUSTAINDRUG DELIVERY SYSTEMS power point
SUSTAINDRUG DELIVERY SYSTEMS power point
 
APPLICATIONS OF PHARMACOKINETICS Piyush lodhi b. pharma 6th sem
APPLICATIONS OF  PHARMACOKINETICS Piyush lodhi b. pharma 6th sem APPLICATIONS OF  PHARMACOKINETICS Piyush lodhi b. pharma 6th sem
APPLICATIONS OF PHARMACOKINETICS Piyush lodhi b. pharma 6th sem
 

Recently uploaded

Transposable elements in prokaryotes.ppt
Transposable elements in prokaryotes.pptTransposable elements in prokaryotes.ppt
Transposable elements in prokaryotes.pptArshadWarsi13
 
Sulphur & Phosphrus Cycle PowerPoint Presentation (2) [Autosaved]-3-1.pptx
Sulphur & Phosphrus Cycle PowerPoint Presentation (2) [Autosaved]-3-1.pptxSulphur & Phosphrus Cycle PowerPoint Presentation (2) [Autosaved]-3-1.pptx
Sulphur & Phosphrus Cycle PowerPoint Presentation (2) [Autosaved]-3-1.pptxnoordubaliya2003
 
preservation, maintanence and improvement of industrial organism.pptx
preservation, maintanence and improvement of industrial organism.pptxpreservation, maintanence and improvement of industrial organism.pptx
preservation, maintanence and improvement of industrial organism.pptxnoordubaliya2003
 
User Guide: Capricorn FLX™ Weather Station
User Guide: Capricorn FLX™ Weather StationUser Guide: Capricorn FLX™ Weather Station
User Guide: Capricorn FLX™ Weather StationColumbia Weather Systems
 
Pests of safflower_Binomics_Identification_Dr.UPR.pdf
Pests of safflower_Binomics_Identification_Dr.UPR.pdfPests of safflower_Binomics_Identification_Dr.UPR.pdf
Pests of safflower_Binomics_Identification_Dr.UPR.pdfPirithiRaju
 
Environmental Biotechnology Topic:- Microbial Biosensor
Environmental Biotechnology Topic:- Microbial BiosensorEnvironmental Biotechnology Topic:- Microbial Biosensor
Environmental Biotechnology Topic:- Microbial Biosensorsonawaneprad
 
STOPPED FLOW METHOD & APPLICATION MURUGAVENI B.pptx
STOPPED FLOW METHOD & APPLICATION MURUGAVENI B.pptxSTOPPED FLOW METHOD & APPLICATION MURUGAVENI B.pptx
STOPPED FLOW METHOD & APPLICATION MURUGAVENI B.pptxMurugaveni B
 
Harmful and Useful Microorganisms Presentation
Harmful and Useful Microorganisms PresentationHarmful and Useful Microorganisms Presentation
Harmful and Useful Microorganisms Presentationtahreemzahra82
 
User Guide: Pulsar™ Weather Station (Columbia Weather Systems)
User Guide: Pulsar™ Weather Station (Columbia Weather Systems)User Guide: Pulsar™ Weather Station (Columbia Weather Systems)
User Guide: Pulsar™ Weather Station (Columbia Weather Systems)Columbia Weather Systems
 
Vision and reflection on Mining Software Repositories research in 2024
Vision and reflection on Mining Software Repositories research in 2024Vision and reflection on Mining Software Repositories research in 2024
Vision and reflection on Mining Software Repositories research in 2024AyushiRastogi48
 
Microphone- characteristics,carbon microphone, dynamic microphone.pptx
Microphone- characteristics,carbon microphone, dynamic microphone.pptxMicrophone- characteristics,carbon microphone, dynamic microphone.pptx
Microphone- characteristics,carbon microphone, dynamic microphone.pptxpriyankatabhane
 
Pests of soyabean_Binomics_IdentificationDr.UPR.pdf
Pests of soyabean_Binomics_IdentificationDr.UPR.pdfPests of soyabean_Binomics_IdentificationDr.UPR.pdf
Pests of soyabean_Binomics_IdentificationDr.UPR.pdfPirithiRaju
 
The dark energy paradox leads to a new structure of spacetime.pptx
The dark energy paradox leads to a new structure of spacetime.pptxThe dark energy paradox leads to a new structure of spacetime.pptx
The dark energy paradox leads to a new structure of spacetime.pptxEran Akiva Sinbar
 
Grafana in space: Monitoring Japan's SLIM moon lander in real time
Grafana in space: Monitoring Japan's SLIM moon lander  in real timeGrafana in space: Monitoring Japan's SLIM moon lander  in real time
Grafana in space: Monitoring Japan's SLIM moon lander in real timeSatoshi NAKAHIRA
 
Scheme-of-Work-Science-Stage-4 cambridge science.docx
Scheme-of-Work-Science-Stage-4 cambridge science.docxScheme-of-Work-Science-Stage-4 cambridge science.docx
Scheme-of-Work-Science-Stage-4 cambridge science.docxyaramohamed343013
 
Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Nistarini College, Purulia (W.B) India
 
BUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdf
BUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdfBUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdf
BUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdfWildaNurAmalia2
 
Pests of jatropha_Bionomics_identification_Dr.UPR.pdf
Pests of jatropha_Bionomics_identification_Dr.UPR.pdfPests of jatropha_Bionomics_identification_Dr.UPR.pdf
Pests of jatropha_Bionomics_identification_Dr.UPR.pdfPirithiRaju
 
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝soniya singh
 
LIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptx
LIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptxLIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptx
LIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptxmalonesandreagweneth
 

Recently uploaded (20)

Transposable elements in prokaryotes.ppt
Transposable elements in prokaryotes.pptTransposable elements in prokaryotes.ppt
Transposable elements in prokaryotes.ppt
 
Sulphur & Phosphrus Cycle PowerPoint Presentation (2) [Autosaved]-3-1.pptx
Sulphur & Phosphrus Cycle PowerPoint Presentation (2) [Autosaved]-3-1.pptxSulphur & Phosphrus Cycle PowerPoint Presentation (2) [Autosaved]-3-1.pptx
Sulphur & Phosphrus Cycle PowerPoint Presentation (2) [Autosaved]-3-1.pptx
 
preservation, maintanence and improvement of industrial organism.pptx
preservation, maintanence and improvement of industrial organism.pptxpreservation, maintanence and improvement of industrial organism.pptx
preservation, maintanence and improvement of industrial organism.pptx
 
User Guide: Capricorn FLX™ Weather Station
User Guide: Capricorn FLX™ Weather StationUser Guide: Capricorn FLX™ Weather Station
User Guide: Capricorn FLX™ Weather Station
 
Pests of safflower_Binomics_Identification_Dr.UPR.pdf
Pests of safflower_Binomics_Identification_Dr.UPR.pdfPests of safflower_Binomics_Identification_Dr.UPR.pdf
Pests of safflower_Binomics_Identification_Dr.UPR.pdf
 
Environmental Biotechnology Topic:- Microbial Biosensor
Environmental Biotechnology Topic:- Microbial BiosensorEnvironmental Biotechnology Topic:- Microbial Biosensor
Environmental Biotechnology Topic:- Microbial Biosensor
 
STOPPED FLOW METHOD & APPLICATION MURUGAVENI B.pptx
STOPPED FLOW METHOD & APPLICATION MURUGAVENI B.pptxSTOPPED FLOW METHOD & APPLICATION MURUGAVENI B.pptx
STOPPED FLOW METHOD & APPLICATION MURUGAVENI B.pptx
 
Harmful and Useful Microorganisms Presentation
Harmful and Useful Microorganisms PresentationHarmful and Useful Microorganisms Presentation
Harmful and Useful Microorganisms Presentation
 
User Guide: Pulsar™ Weather Station (Columbia Weather Systems)
User Guide: Pulsar™ Weather Station (Columbia Weather Systems)User Guide: Pulsar™ Weather Station (Columbia Weather Systems)
User Guide: Pulsar™ Weather Station (Columbia Weather Systems)
 
Vision and reflection on Mining Software Repositories research in 2024
Vision and reflection on Mining Software Repositories research in 2024Vision and reflection on Mining Software Repositories research in 2024
Vision and reflection on Mining Software Repositories research in 2024
 
Microphone- characteristics,carbon microphone, dynamic microphone.pptx
Microphone- characteristics,carbon microphone, dynamic microphone.pptxMicrophone- characteristics,carbon microphone, dynamic microphone.pptx
Microphone- characteristics,carbon microphone, dynamic microphone.pptx
 
Pests of soyabean_Binomics_IdentificationDr.UPR.pdf
Pests of soyabean_Binomics_IdentificationDr.UPR.pdfPests of soyabean_Binomics_IdentificationDr.UPR.pdf
Pests of soyabean_Binomics_IdentificationDr.UPR.pdf
 
The dark energy paradox leads to a new structure of spacetime.pptx
The dark energy paradox leads to a new structure of spacetime.pptxThe dark energy paradox leads to a new structure of spacetime.pptx
The dark energy paradox leads to a new structure of spacetime.pptx
 
Grafana in space: Monitoring Japan's SLIM moon lander in real time
Grafana in space: Monitoring Japan's SLIM moon lander  in real timeGrafana in space: Monitoring Japan's SLIM moon lander  in real time
Grafana in space: Monitoring Japan's SLIM moon lander in real time
 
Scheme-of-Work-Science-Stage-4 cambridge science.docx
Scheme-of-Work-Science-Stage-4 cambridge science.docxScheme-of-Work-Science-Stage-4 cambridge science.docx
Scheme-of-Work-Science-Stage-4 cambridge science.docx
 
Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...
 
BUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdf
BUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdfBUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdf
BUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdf
 
Pests of jatropha_Bionomics_identification_Dr.UPR.pdf
Pests of jatropha_Bionomics_identification_Dr.UPR.pdfPests of jatropha_Bionomics_identification_Dr.UPR.pdf
Pests of jatropha_Bionomics_identification_Dr.UPR.pdf
 
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
 
LIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptx
LIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptxLIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptx
LIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptx
 

CONCEPT OF LOADING AND MAINTAINANCE DOSE.pptx

  • 1. CONCEPT OF LOADING AND MAINTENANCE DOSE 6/5/2022 1
  • 2. CONTENT  INTRODUCTION  DEFINITION  CONCEPT  FACTORS  REFERENCE 6/5/2022 2
  • 3. INTRODUCTION  Most drugs for chronic condition are prescribed in a dosage regimen is based on the administration of a fixed constant dose(D) at fixed regular dosing intervals(T) for long period of time.  The D & T recommended by the manufacturer is based on the effective therapeutic concentration of drug in the plasma needed to treat the chronic condition. 6/5/2022 3
  • 4.  The T is based on elimination rate constant of the drug.  The steady-state concentration of drug in plasma during multiple dosing is given by following equation: 6/5/2022 4
  • 5.  The concentration of drug in plasma at steady-state depends on the following 3 factors: a) C0, concentration of drug in plasma. b) Ke, elimination rate constant. c) T, the dosing interval. 6/5/2022 5
  • 6. DEFINITION & CONCEPT  Loading dose: A dose of medication, often larger than subsequent doses, administered for the purpose of establishing a therapeutic level of the medication.  Primary purpose of using loading dose in therapeutic treatment is to attain steady- state concentration of the drug as quickly as possible, usually right from the start of the dosage regimen for the treatment. 6/5/2022 6
  • 7.  This approach may also reduce the time of onset of drug action, i.e; the time its takes to achieve the minimum effective concentration.  The purpose of administering the loading dose is to reduce the time needed for the drug to accumulate to the steady-state level in the plasma.  The size of loading dose will depend on the T of the maintenance dose. 6/5/2022 7
  • 8. INTRAVENOUS ADMINISTRATION  A drug when administered intravenously as a single rapid bolus dose, confers the characteristics of one-compartment model on the body.  The main purpose of loading dose(D*) is to provide a steady-state concentration in plasma during multiple dosing. 6/5/2022 8
  • 9. Loading dose based on Cmax ss  The max concentration of drug in the plasma at steady-state, Cmax ss is given by equation C0 is plasma concentration immediately after administration of a single dose. e-p is persistence factor where P=(Ke) (T) 6/5/2022 9
  • 10.  If the drug follows linear pharmacokinetics then C0 obtained after the administration of single i.v rapid bolus dose is directly proportional to size of dose D(maintenance dose).  The max concentration at steady-state is 6/5/2022 10
  • 11.  Concentration of drug in plasma immediately after administration of the first dose is given by  Vd= apparent volume of distribution  therefore 6/5/2022 11
  • 12.  The max conc after the first dose is  Since Cmax 1 = Cmaxss, the conc *C0 of drug in plasma immediately after (D*) is given by *C0 = Cmaxss  Substuting *C0 and Cmaxss gives 6/5/2022 12
  • 13.  The size of loading dose depends on the following factors- a) Maintenance dose ,D b) Elimination rate constant , Ke c) Dosing interval ,T. 6/5/2022 13
  • 14. Loading dose based on Cmin ss  The minimum concentration of drug in plasma at steady-state is given by equation  If drug follows linear p’kinetics then C0 is directly proportional to size of D  The min concentration of drug in plasma at steady-state is 6/5/2022 14
  • 15.  When a single bolus dose of the drug is administered intravenously  Therefore 6/5/2022 15
  • 16.  The min conc of drug in plasma after administration of first dose  For D* Cmin 1 = (*C0 ) (e-p ),which should be equal to Cmin ss  Combining eq 6/5/2022 16
  • 17.  Common terms canceled 6/5/2022 17
  • 18. Factors affecting size of dose  If all doses and all T are kept constant, then the size of D depends on size of D*, T & Ke Effect of dosing interval:  If the size of D is kept constant & biological halflife of the drug dose not change during the course of therapy, the size of D* depends entirely upon the T of a given drug. 6/5/2022 18
  • 19. EXTRAVASCULAR ADMINISTRATION  For the determination of D* during e.v, administration, the simplest case is a drug which, when administered, confers upon the body the characteristics of one-compartment model, & does not exhibit lag-time.  The size of D* needed to attain steady-sate conc of drug in plasma depends on: 6/5/2022 19
  • 20. a. Maximum concentration of drug in plasma at steady state. OR b. Minimum concentration of drug in plasma at steady state. LOADING DOSE BASED ON Cmaxss  The maximum concn of drug in plasma at steady-state is given by 6/5/2022 20
  • 21.  Where B is the back extrapolated y- intercept of the elimination phase after administration of a single dose.  R=(Ke) (tmax) 6/5/2022 21
  • 22. Loading dose based on Cmin ss  The minimum conc of drug in plasma following e.v adminstration of n dose  If the drug follows linear pharmacokinetics then B  F=fraction of dose absorbed  G= (Ka)( T) 6/5/2022 22
  • 23.  By setting n=1 in above eq in Cmin1  Canceling common terms  When n becomes large, the two exponential terms e-np e-nG approach 0 6/5/2022 23
  • 24.  Since the y-intercept,Cmin1 is directly proportional to D  If D is administered at the first dose 6/5/2022 24
  • 25.  When Cmin1=Cminss  Substituting the values  Bringing RHS of eq to common denominator  Upon simplification 6/5/2022 25
  • 26.  Dividing both side by (e-p – e-G)  Cancelling common term 6/5/2022 26
  • 27. Maintenance Dose  After the loading dose is given the another dose is given to maintain the steady- state drug conc. / plateau. Such dose is known as maintenance dose.  i.e. maintain the response of drug by replacing drug lost during dosing interval 6/5/2022 27
  • 28.  Maintenance dose = loading dose . ( 1- e k‫ז‬)  Loading dose =  The ratio of loading dose to maintenance dose (X0l/X0) is called as dose ratio  When ‫ז‬ = t1/2 the dose ratio =2.0  When ‫ז‬ > t1/2 the dose ratio < 2.0  when ‫ז‬ < t1/2 the dose ratio >2.0 6/5/2022 28
  • 30. Maintenance of drug within the therapeutic range The ease or difficulty in maintaining drug concentration within the therapeutic window depends on-  The Therapeutic index of drug  The Half- life of drug  Convenience of dosing 6/5/2022 30
  • 31. REFERENCE  Madan PL;Biopharmaceutics and pharmacokinetics. Jaypee.2010(1);365-80.  Brahmankar DM, Sunil Jaiswal B; Biopharmaceutics and Pharmacokinetics- A Treatise. Vallabh publication. 2014(3); 374-76.  C V S Subrahmanyam. Textbook of Biopharmaceutics & pharmacokinetics.1st edition 2010;456-61. 6/5/2022 31